John C. Martin News
Most Popular John C. Martin Story
Gilead CEO John C. Martin - CEO pay report
John C. Martin - Gilead Total Compensation: $10.8 million Details: Martin received roughly $1 million in salary, $1.6 million in bonuses and $3,800 in "other" compensation. Most of Martin's slary... Read more...
Latest Headlines
- June 16, 2009
- April 25, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
